Rufinamide add-on therapy for refractory epilepsy

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: We aim to review and synthesise evidence from randomised controlled trials of rufinamide used as add-on therapy for patients with refractory epilepsy. The primary objective is to evaluate the efficacy and tolerability of rufinamide in treating individuals with refractory epilepsy.